|
Volumn 18, Issue 2, 2012, Pages 221-223
|
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
K RAS PROTEIN;
MITOGEN ACTIVATED PROTEIN KINASE;
PANITUMUMAB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN KINASE B;
APOPTOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER INHIBITION;
CANCER RESISTANCE;
CANCER SURVIVAL;
CELL PROLIFERATION;
CELL SURVIVAL;
CELL VIABILITY;
CLINICAL ARTICLE;
COLORECTAL CANCER;
COMPUTER ASSISTED TOMOGRAPHY;
DNA SEQUENCE;
DRUG BINDING;
DRUG MECHANISM;
EXTRACELLULAR SPACE;
GENE AMPLIFICATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VITRO STUDY;
MOLECULAR CLONING;
MUTATIONAL ANALYSIS;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
SINGLE NUCLEOTIDE POLYMORPHISM;
WILD TYPE;
|
EID: 84856717005
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.2609 Document Type: Article |
Times cited : (414)
|
References (7)
|